After adjusting for baseline AST/ALT levels, baseline CD4+ count, alcohol use, BMI, HIV risk factors, diabetes, age, sex, and HBsAb positivity, pOBI remained unassociated with the risk of transaminase elevation, with minimal changes in the hazard ratio estimates for both cohorts (Table 2). This evidence concerns the gene GPT and diabetes mellitus.